. Recent Developments in LRRK2-Targeted Therapy for Parkinson's Disease. Drugs. 2019 Jul;79(10):1037-1051. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.